DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response.
Ab's to the alpha-chain of the IL-2 receptor (anti-CD25) are used clinically to achieve immunosuppression. Here we investigated the effects of DNA vaccination with the whole CD25 gene on the induction of rat adjuvant arthritis. The DNA vaccine protected the rats and led to a shift in the cytokine profile of T cells responding to disease target antigens from Th1 to Th2. The mechanism of protection was found to involve the induction of an antiergotypic response, rather than the induction of anti-CD25 Ab's. Antiergotypic T cells respond to activation molecules, ergotopes, expressed on syngeneic activated, but not resting, T cells. CD25-derived peptides function as ergotopes that can be recognized by the antiergotypic T cells. Antiergotypic T cells taken from control sick rats did not proliferate against activated T cells and secreted mainly IFN-gamma. In contrast, antiergotypic cells from CD25-DNA-protected rats proliferated against activated T cells and secreted mainly IL-10. Protective antiergotypic T cells were found in both the CD4+ and CD8+ populations and expressed alpha/beta or gamma/delta T cell receptors. Antiergotypic alpha/beta T cells were MHC restricted, while gamma/delta T cells were MHC independent. Thus, CD25 DNA vaccination may induce protection from autoimmunity by inducing a cytokine shift in both the antiergotypic response and the response to the antigens targeted in the disease.
Mimran
Avishai
A
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Mor
Felix
F
Carmi
Pnina
P
Quintana
Francisco J
FJ
Rotter
Varda
V
Cohen
Irun R
IR
D000818:Animals; D000941:Antigens / Q000187:drug effects / Q000276:immunology; D001169:Arthritis, Experimental / Q000276:immunology / Q000517:prevention & control*; D002455:Cell Division / Q000187:drug effects; D016207:Cytokines / Q000187:drug effects; D015536:Down-Regulation; D005260:Female; D051381:Rats; D011917:Rats, Inbred Lew; D015375:Receptors, Interleukin-2 / Q000235:genetics* / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects; D019444:Vaccines, DNA / Q000276:immunology* / Q000494:pharmacology
D000941:Antigens; D016207:Cytokines; D015375:Receptors, Interleukin-2; D019444:Vaccines, DNA